Clinical Trials

1,821 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Phase 4 Unknown

70 enrolled

Breast Neoplasms

NCT05200078 2022-01-20

Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer

166 enrolled

Breast Neoplasms, Cardiovascular Diseases

NCT05068115 2021-10-13

Characteristics and Treatment Trends of Young Breast Cancer in China

1,000 enrolled

Breast Neoplasms

NCT05045287 2021-09-16

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Phase NA Unknown

57 enrolled

Breast Neoplasms

NCT01917279 2020-07-23

CAMELLIA

Phase 3 Unknown

280 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT04289974 2020-02-28

Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

100 enrolled

Breast Neoplasms

NCT04194684 2019-12-11

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

108 enrolled

Breast Neoplasms

NCT04033172 2019-07-25

Pyrotinib

40 enrolled

Breast Neoplasms

NCT02768415 2019-06-19

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

40 enrolled

Breast Neoplasms

NCT03933982 2019-05-29

Pyrotinib

30 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03947736 2019-05-14

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

200 enrolled

Breast Neoplasms, Recurrence

NCT03923166 2019-04-22

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

35 enrolled

Breast Neoplasms

NCT03923179 2019-04-22

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

32 enrolled

Breast Neoplasms

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

29 enrolled

Breast Neoplasms

NCT02646735 2017-01-02

FRIEND

148 enrolled

Breast Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

230 enrolled

Breast Neoplasms

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

120 enrolled

Breast Neoplasms

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

33 enrolled 5 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

200 enrolled

Breast Neoplasms

NCT01492556 2013-03-15

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

100 enrolled

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT01431053 2013-03-13

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

160 enrolled

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Phase 3 Unknown

100 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase 3 Unknown

200 enrolled

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT01278810 2011-01-28

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Phase 1 Unknown

30 enrolled